ASX:IDXIntegral Diagnostics Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Integral Diagnostics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day RangeA$2.27MA: A$3.93▼A$4.2652-Week Range N/AVolume952,779 shsAverage VolumeN/AMarket Capitalization$418.27 millionP/E Ratio17.06Dividend Yield4.84%BetaN/A ProfileAdvanced ChartDividendHeadlines Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia. The company provides its services through a network of 53 sites under the Lake Imaging, South Coast Radiology, and Global Diagnostics brands in Victoria, Queensland, and Western Australia, as well as through specialist Radiology Group, and Trinity MRI and Cavendish Radiology in Auckland, New Zealand. Integral Diagnostics Limited is headquartered in North Melbourne, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Integral Diagnostics. Previous Next 2.5 Community Rank Outperform VotesIntegral Diagnostics has received 14 “outperform” votes. (Add your “outperform” vote.)Underperform VotesIntegral Diagnostics has received 14 “underperform” votes. (Add your “underperform” vote.)Community SentimentIntegral Diagnostics has received 50.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Integral Diagnostics and other stocks. Vote “Outperform” if you believe IDX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IDX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipIntegral Diagnostics is a leading dividend payer. It pays a dividend yield of 4.84%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthIntegral Diagnostics does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Integral Diagnostics is 79.37 %. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Integral Diagnostics insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Integral Diagnostics is 17.06, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 11.23.Price to Earnings Ratio vs. SectorThe P/E ratio of Integral Diagnostics is 17.06, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 19.79. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.96 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolASX:IDX Previous Symbol CUSIPN/A CIKN/A Webhttp://www.integraldiagnostics.com.au/ Phone61 3 5339 0704Debt Debt-to-Equity Ratio113.20 Current Ratio0.78 Quick Ratio0.66Price-To-Earnings Trailing P/E Ratio17.06 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$249.55 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow24.64 Book ValueA$1.16 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees928 Outstanding Shares194,544,992Market Cap$418.27 million Next Earnings DateN/A OptionableNot Optionable Receive IDX News and Ratings via Email Sign-up to receive the latest news and ratings for IDX and its competitors with MarketBeat's FREE daily newsletter. Integral Diagnostics (ASX:IDX) Frequently Asked Questions How often does Integral Diagnostics pay dividends? What is the dividend yield for Integral Diagnostics? Integral Diagnostics declared a Interim dividend on Friday, February 21st. Stockholders of record on Tuesday, April 7th will be paid a dividend of 0.055 per share on Tuesday, April 7th. This represents a dividend yield of 1.29%. The ex-dividend date is Friday, February 28th. This is a positive change from Integral Diagnostics's previous Interim dividend of $0.05. View Integral Diagnostics' dividend history. Has Integral Diagnostics been receiving favorable news coverage? News articles about IDX stock have been trending very negative recently, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Integral Diagnostics earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutIntegral Diagnostics. Who are some of Integral Diagnostics' key competitors? Some companies that are related to Integral Diagnostics include Senseonics (SENS), Volpara Health Tech (VHT), Profound Medical (PRN), Exagen (XGN), Akumin (AKU), Renalytix Ai (RENX), Palatin Technologies (PTN), Yourgene Health (YGEN), Oncosil Medical (OSL), MaxCyte (MXCT), BARD1 Life Sciences (BD1), Lexagene (LXG), Oncimmune (ONC), SQI Diagnostics (SQD) and GeneNews (GEN). Who are Integral Diagnostics' key executives? Integral Diagnostics' management team includes the following people: Dr. Ian Kadish, CEO, MD & Director (Age 56)Ms. Anne Lockwood, Chief Financial OfficerDr. Chien Ping Ho, Exec. DirectorDr. Sally Sojan, Exec. DirectorMrs. Kathryn Davies BBus, GAICD, CPA, Company Sec. What is Integral Diagnostics' stock symbol? Integral Diagnostics trades on the ASX under the ticker symbol "IDX." How big of a company is Integral Diagnostics? Integral Diagnostics has a market capitalization of $0.00 and generates $249.55 million in revenue each year. Integral Diagnostics employs 928 workers across the globe. View additional information about Integral Diagnostics. What is Integral Diagnostics' official website? The official website for Integral Diagnostics is http://www.integraldiagnostics.com.au/. How can I contact Integral Diagnostics? The company can be reached via phone at 61 3 5339 0704. This page was last updated on 4/3/2020 by MarketBeat.com StaffFeatured Article: Cost of Capital
